Enzovax®
A live vaccine for the active immunisation of susceptible female breeding sheep to reduce abortion caused by Chlamydophila abortus infection. The vaccine is reconstituted with Unisolve immediately prior to use, allowing 2 ml of solvent per dose. An administration kit including a vented transfer device for vaccine reconstitution and disposable automatic syring is available.
Presentation
Lyophilisate and solvent for suspension for injection
Lyophilisate: Off-white to cream-coloured pellet
Solvent: Colourless solution
Active ingredients
Live, attenuated strain ts 1B Chlamydophila abortus 105.0 -106.9 IFU per dose*.
* Inclusion-body Forming Units.
Target species
Sheep
Indications for use
Enzovax is a live vaccine for the active immunisation of susceptible female breeding sheep to reduce abortion caused by Chlamydophila abortus infection, and reduce shedding of Chlamydophila abortus. A single 2 ml dose of vaccine is required at least 4 weeks before mating. Ewe lambs, where it is intended to breed from them, may be vaccinated from 5 months of age. The vaccine may be used at the same time as Toxovax.
Withdrawal periods
Sheep - Meat and offal 7 days
Packaging
Carton with 1 vial of vaccine, 1 vial of Unisolve and one transfer spike. Vials containing 10, 20 or 50 doses supplied together with Unisolve.
Not all pack sizes may be marketed.
Legal category
POM-V
Further information is available from the SPC, datasheet or package leaflet.
Advice should be sought from the medicine prescriber.
Prescription decisions are for the person issuing the prescription alone.
Use Medicines Responsibly.
Date of preparation: May 2024
Toxovax® contains Toxoplasma gondii. POM-V
Further information is available from the SPC, datasheet or package leaflet. Further information is available from the SPC, datasheet or package leaflet.
Advice should be sought from the medicine prescriber.
Prescription decisions are for the person issuing the prescription alone.
Use Medicines Responsibly.